Press release
Cord Blood Registry® Announces Thought Leadership Role at Cord Blood Connect
Marquee industry conference will showcase data from CBR's Newborn Possibilities Program® TRUMBULL, Conn., Sept. 8, 2023 /PRNewswire/ -- CooperSurgical, a
About this update from The Cooper Companies, Inc.
[{"type":"text","content":"Marquee industry conference will showcase data from CBR's Newborn Possibilities Program® \nTRUMBULL, Conn., Sept. 8, 2023 /PRNewswire/ -- CooperSurgical, a global leader in fertility and women's health, announced that Cord Blood Registry® (CBR®) will have a key role in the upcoming Cord Blood Connect meeting from September 8th – 11th, which is the annual meeting of the Cord Blood Association. The Cord Blood Association is an international nonprofit organization that promotes both public and family newborn stem cell preservation and accelerates the use of cord blood and birthing tissues to benefit patients and advance medicine.\n\n \n \n \n \n \n \n\n \n\"Cord Blood Connect is a critical meeting for public and family cord blood banks, allowing them a forum to discuss industry innovations, patient needs, and evolving industry standards,\" stated Holly Sheffield, President, CooperSurgical. \"We are proud to be the Platinum Sponsor of this event, and to be presenting new scientific data, as well as moderating a forum with key industry voices to discuss the future of cord blood banking. Our presence and participation is one example of CooperSurgical's commitment to elevating this industry.\"\nCBR's abstract titled \"Experience with enrollments and releases within a medical needs program at a large U.S. private cord blood bank\" was accepted as a poster presentation at Cord Blood Connect. The objective of the study was to examine indications for enrollments and unit releases in CBR's Newborn Possibilities Program. Through this program, CBR offers free cord blood and tissue processing and five years of storage for families with a qualifying medical need. The results of the study suggested the structure of the Newborn Possibilities Program is effective in identifying families who have a higher likelihood of utilizing their cord blood unit for a transplant or experimental infusion. The investigators also noted that cord blood banks should continue to re-evaluate the eligibility criteria for their medical needs program in light of relevant updates in the potential utility of newborn stem cells including changes in transplant medicine indications and treatment procedures, as well as clinical trials and experimental protocols using related cord blood units. Future research related to pathways of referral to medical needs programs may inform...